Systemic Crisis at the FDA: Unpacking the Consequences of Regulatory Erosion
Original framing: “Opinion: STAT+: Dark times ahead at the FDA” — STAT News
The FDA's regulatory erosion is part of a broader pattern of deregulation and corporate influence in the United States, dating back to the 1980s. The agency's failure to regulate medical products effectively has led to numerous scandals and public health crises, including the opioid epidemic. Score: 0.9
The FDA's regulatory erosion is a symptom of a broader systemic crisis, driven by the Trump administration's intentional dismantling of the agency's authority.
This crisis has far-reaching consequences for public health, as it undermines the FDA's ability to ensure the safety and efficacy of medical products. To address this crisis, it is essential to strengthen regulatory oversight, promote public health and regulatory oversight, and address corporate influence and profit over people. By prioritizing public health and regulatory oversight, the FDA can ensure the safety and efficacy of medical products and protect the public from harm.